Outcome of Jehovah's Witnesses after adult cardiac surgery: systematic review and meta-analysis of comparative studies

Transfusion

Volumn 56, Issue 8, 2016, Pages 2146-2153

  Vasques, Francesco ^a   Kinnunen, Eeva Maija ^b   Pol, Marek ^c   Mariscalco, Giovanni ^d   Onorati, Francesco ^e   Biancari, Fausto ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ERYTHROPOIETIN; HEMOGLOBIN; TRANEXAMIC ACID;

ADULT; ATRIAL FIBRILLATION; BLEEDING; BLOOD SALVAGE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; HEART INFARCTION; HEART SURGERY; HEMODILUTION; HUMAN; INTENSIVE CARE UNIT; JEHOVAH'S WITNESS; LENGTH OF STAY; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; REOPERATION; REVIEW; SCOPUS; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 84982915265     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13657     Document Type: Review

References (31)

1. Ascione R, Williams S, Lloyd CT, et al. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 2001;121:689–96.
2. Görlinger K, Shore-Lesserson L, Dirkmann D, et al. Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth 2013;27:S20–34.
3. Ranucci M, Baryshnikova E, Castelvecchio S, et al. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013;96:478–85.
4. Hung M, Besser M, Sharples LD, et al. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia 2011;66:812–8.
5. Pompei E, Tursi V, Guzzi G, et al. Mid-term clinical outcomes in cardiac surgery of Jehovah's witnesses. J Cardiovasc Med 2010;11:170–4.
6. Marshall L, Krampl C, Vrtik M, et al. Short term outcomes after cardiac surgery in a Jehovah's Witness population: an institutional experience. Heart Lung Circ 2012;21:101–4.
7. Juraszek A, Dziodzio T, Roedler S, et al. Results of open heart surgery in Jehovah's Witnesses patients. J Cardiovasc Surg 2009;50:247–50.
8. El-Essawi A, Breitenbach I, Ali K, et al. Minimized perfusion circuits: an alternative in the surgical treatment of Jehovah's Witnesses. Perfusion 2013;28:47–53.
9. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
10. Bhaskar B, Jack RK, Mullany D, et al. Comparison of outcome in Jehovah's Witness patients in cardiac surgery: an Australian experience. Heart Lung Circ 2010;19:655–9.
11. Guinn NR, Roberson RS, White W, et al. Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study. Transfusion 2015;55:2791–8.
12. Pattakos G, Koch CG, Brizzio ME, et al. Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med 2012;172:1154–60.
13. Reyes G, Nuche JM, Sarraj A, et al. [Bloodless cardiac surgery in Jehovah's Witnesses: outcomes compared with a control group.] Rev Esp Cardiol 2007;60:727–31. In Spanish.
14. Stamou SC, White T, Barnett S, et al. Comparisons of cardiac surgery outcomes in Jehovah's versus non-Jehovah's Witnesses. Am J Cardiol 2006;98:1223–5.
15. Vaislic C, Bical O, Farge C, et al. Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah's Witnesses. Heart Surg Forum 2003;6:307–10.
16. Biancari F, Mikkola R, Heikkinen J, et al. Estimating the risk of complications related to re-exploration for bleeding after adult cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2012;41:50–5.
17. Biancari F, Mikkola R, Heikkinen J, et al. Individual surgeon's impact on the risk of re-exploration for excessive bleeding after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2012;26:550–6.
18. Haneya A, Diez C, Kolat P, et al. Re-exploration for bleeding or tamponade after cardiac surgery: impact of timing and indication on outcome. Thorac Cardiovasc Surg 2015;63:51–7.
19. Goodnough LT, Shander A. Patient blood management. Anesthesiology 2012;116:1367–76.
20. Hogervorst EK, Rosseel PM, van de Watering LM, et al. Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. J Cardiothorac Vasc Anesth 2016;30:363–72.
21. Freeland K, Hamidian Jahromi A, Duvall LM, et al. Postoperative blood transfusion is an independent predictor of acute kidney injury in cardiac surgery patients. J Nephropathol 2015;4:121–6.
22. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015;372:997–1008.
23. Reeves BC, Murphy GJ. Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opin Anaesthesiol 2008;21:669–73.
24. Williams ML, He X, Rankin JS, et al. Preoperative hematocrit is a powerful predictor of adverse outcomes in coronary artery bypass graft surgery: a report from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2013;96:1628–34.
25. Tanaka A, Ota T, Uriel N, et al. Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. J Thorac Cardiovasc Surg 2015;150:976–83.e1-3.
26. Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008;117:478–84.
27. Piednoir P, Allou N, Driss F, et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. Eur J Anaesthesiol 2011;28:796–801.
28. Cladellas M, Farré N, Comín-Colet J, et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol 2012;110:1021–6.
29. D'Ambra MN, Gray RJ, Hillman R, et al. The effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 1997;64:1686–93.
30. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753–65.
31. Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012;52:1983–8.